Clinical Trials Logo

Immunosuppressed clinical trials

View clinical trials related to Immunosuppressed.

Filter by:
  • None
  • Page 1

NCT ID: NCT05020145 Completed - Covid-19 Clinical Trials

COVID-19 Vaccination and Breakthrough Infections Among Persons With Immunocompromising Conditions in the United States

Start date: August 25, 2021
Phase:
Study type: Observational

This retrospective study will evaluate characteristics, vaccine utilization and outcomes among subjects with immunocompromising conditions that received COVID-19 vaccination.

NCT ID: NCT01022931 Completed - Healthy Clinical Trials

Epidemiology and Clinical Presentation of H1N1 Infection in Children in Geneva

Start date: October 2009
Phase: N/A
Study type: Observational

This study aims to identify clinical symptoms and outcomes, as well as response to anti-viral treatment in children living in Geneva, with influenza A/ H1N1 infection during the current pandemic.

NCT ID: NCT00716989 Terminated - Healthy Clinical Trials

Pathophysiological Study of Characteristics of the Changes in the Cutaneous Immune System After Intradermal Antigen Injections

LBP003
Start date: November 2008
Phase: N/A
Study type: Interventional

The goal of the vaccination is to induce humoral (antibody) and intracellular (T lymphocyte) responses. Various data show that intradermal vaccination is more efficient than intramuscular vaccination: the humoral response is statistically better after intradermic vaccination, compared to intramuscular vaccination, even in target populations such as older subjects or immunosuppressed patients